Published in J Bacteriol on August 01, 1973
Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc Natl Acad Sci U S A (1981) 2.56
Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest (1975) 2.16
Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes. J Exp Med (1974) 1.82
Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. J Clin Invest (1976) 1.61
Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J Clin Invest (1985) 1.50
The inhibition of bacterial growth by hypochlorous acid. Possible role in the bactericidal activity of phagocytes. Biochem J (1988) 1.29
Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens. Infect Immun (1975) 1.23
Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest (1990) 1.18
Effects of the putative neutrophil-generated toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli. J Clin Invest (1986) 1.18
Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases. J Clin Invest (1990) 1.16
Persistence of regulation of macromolecular synthesis by Escherichia coli during killing by disrupted rabbit granulocytes. Infect Immun (1974) 1.14
Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia. Infect Immun (1980) 1.14
Hypochlorous acid-promoted loss of metabolic energy in Escherichia coli. Infect Immun (1987) 1.12
Bacterial antigen immunolabeling in macrophages after phagocytosis and degradation of Bacillus subtilis. Infect Immun (1988) 1.09
Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2. J Clin Invest (1994) 1.06
Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase. J Clin Invest (1984) 1.02
In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin. Infect Immun (1986) 0.96
Altered phospholipid metabolism in Escherichia coli accompanying killing by disrupted granulocytes. Infect Immun (1975) 0.96
Augmentation of glucose transport in macrophages after particle ingestion. Infect Immun (1974) 0.90
Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli. Infect Immun (1996) 0.90
Heparin inhibits phagocytosis by polymorphonuclear leukocytes. Infect Immun (1981) 0.89
DNA release as a direct measure of microbial killing by phagocytes. Infect Immun (1978) 0.82
Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol. Antimicrob Agents Chemother (1981) 0.82
Respiratory burst facilitates the digestion of Escherichia coli killed by polymorphonuclear leukocytes. Infect Immun (1987) 0.81
The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem (1959) 17.39
Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature (1970) 9.07
The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages. J Exp Med (1963) 5.96
Production and ultrastructure of lysozyme and ethylenediaminetetraacetate-lysozyme spheroplasts of Escherichia coli. J Bacteriol (1967) 4.77
The stimulatory effect of cyclic adenosine 3'5'-monophosphate on DNA-directed synthesis of beta-galactosidase in a cell-free system. Proc Natl Acad Sci U S A (1969) 3.98
Thymidine and thymine incorporation into deoxyribonucleic acid: inhibition and repression by uridine of thymidine phosphorylase of Escherichia coli. J Bacteriol (1967) 2.41
Locus of the lethal event in the serum bactericidal reaction. J Bacteriol (1968) 2.35
Intraleukocytic microbicidal defects. Annu Rev Med (1971) 2.14
Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction. J Bacteriol (1968) 1.99
Mucopeptide metabolism during growth and sporulation in Bacillus megaterium. J Biol Chem (1970) 1.41
Effects of serum components on gram-negative bacteria during bactericidal reactions. Infect Immun (1971) 1.39
Increased synthesis of phospholipid during phagocytosis. J Clin Invest (1968) 1.39
Effects of levorphanol on phospholipid metabolism and composition in Escherichia coli. Biochim Biophys Acta (1971) 1.28
Regulation of lac transcription in Escherichia coli by cyclic adenosine 3',5'-monophosphate. Studies with deoxyribonucleic acid-ribonucleic acid hybridization and hybridization competition. J Biol Chem (1970) 1.06
Respiration and protein synthesis in Escherichia coli membrane-envelope fragments. IV. Chemical and cytological characterization and biosynthetic capabilities of fragments obtained by mild procedures. J Cell Biol (1972) 0.96
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15
Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest (1980) 2.99
A reevaluation of the roles of the O2-dependent and O2-independent microbicidal systems of phagocytes. Rev Infect Dis (1983) 2.35
Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem (1989) 2.29
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest (1975) 2.16
Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system. J Clin Invest (1982) 2.04
Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Invest (1983) 1.93
A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem (1987) 1.86
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J Clin Invest (1992) 1.82
Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes. J Exp Med (1974) 1.82
Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med (1991) 1.80
The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol (1984) 1.67
Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules. J Lipid Res (1974) 1.59
Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 1.56
The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest (1996) 1.54
Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest (1990) 1.52
The interaction in vitro between polymorphonuclear leukocytes and mycoplasma. J Exp Med (1971) 1.50
Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J Clin Invest (1985) 1.50
Phospholipid metabolism by phagocytic cells. I. A comparison of conversion of [32P]lysolecithin to lecithin and glycerylphosphorylcholine by homogenates of rabbit polymorphonuclear leukocytes and alveolar macrophages. Biochim Biophys Acta (1966) 1.50
Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J Biol Chem (1993) 1.48
Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. J Immunol (1989) 1.44
Isolation and characterization of a phospholipase A2 from an inflammatory exudate. J Lipid Res (1978) 1.42
On the interaction between phagocytes and micro-organisms. N Engl J Med (1973) 1.40
Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction. Biochim Biophys Acta (1976) 1.39
Increased synthesis of phospholipid during phagocytosis. J Clin Invest (1968) 1.39
Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest (1994) 1.34
Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem (1990) 1.32
Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest (1995) 1.29
Effects of levorphanol on phospholipid metabolism and composition in Escherichia coli. Biochim Biophys Acta (1971) 1.28
Biochemical studies of synapses in vitro. I. Protein synthesis. Biochemistry (1968) 1.27
Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J Biol Chem (1994) 1.25
Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens. Infect Immun (1975) 1.23
Phospholipid metabolism by phagocytic cells. VI. Observations on the fate of phospholipids of granulocytes and ingested Escherichia coli during phagocytosis. Biochim Biophys Acta (1972) 1.22
Phospholipid metabolism by phagocytic cells. VII. The degradation and utilization of phospholipids of various microbial species by rabbit granulocytes. Biochim Biophys Acta (1972) 1.21
Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils. Infect Immun (1982) 1.19
An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci U S A (1997) 1.19
Phospholipases and phospholipid turnover in Escherichia coli spheroplasts. Biochim Biophys Acta (1972) 1.19
Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest (1990) 1.18
Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem (1997) 1.17
Degradation of microorganisms by phagocytic cells. Rev Infect Dis (1980) 1.16
Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases. J Clin Invest (1990) 1.16
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. J Immunol (1993) 1.15
Persistence of regulation of macromolecular synthesis by Escherichia coli during killing by disrupted rabbit granulocytes. Infect Immun (1974) 1.14
The use of a phospholipase A-less Escherichia coli mutant to establish the action of granulocyte phospholipase A on bacterial phospholipids during killing by a highly purified granulocyte fraction. Biochim Biophys Acta (1977) 1.12
Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry (1986) 1.11
Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol (1991) 1.10
The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis. J Clin Invest (1971) 1.10
Some properties of phospholipases of alveolar macrophages. Biochim Biophys Acta (1973) 1.10
Phospholipase A2 activity in the plasma membrane of human polymorphonuclear leukocytes. FEBS Lett (1981) 1.07
Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2. J Clin Invest (1994) 1.06
Metabolism of phospholipids by polymorphonuclear leukocytes. Biochim Biophys Acta (1965) 1.05
Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. J Immunol (1995) 1.05
Increased lecithin synthesis during phagocytosis by normal leukocytes and by leukocytes of a patient with chronic granulomatous disease. N Engl J Med (1969) 1.04
Cellular triglyceride as a source of fatty acid for lecithin synthesis during phagocytosis. Biochim Biophys Acta (1969) 1.04
Determinants of the action of phospholipases A on the envelope phospholipids of Escherichia coli. J Biol Chem (1979) 1.03
Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes. Biochim Biophys Acta (1986) 1.02
Phospholipase A activity of lysosomes of rat myocardial tissue. Biochemistry (1972) 1.00
Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria. J Clin Invest (1999) 0.99
Identification of phospholipase A 1 and A 2 in the soluble fraction of rat liver lysosomes. Biochemistry (1971) 0.99
Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles. Infect Immun (1988) 0.98
The role of intramembrane Ca2+ in the hydrolysis of the phospholipids of Escherichia coli by Ca2+-dependent phospholipases. J Biol Chem (1985) 0.98
A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS. J Leukoc Biol (1993) 0.97
Metabolism of lysophosphatidyl ethanolamine and lysophosphatidyl choline by homogenates of rabbit polymorphonuclear leukocytes and alveolar macrophages. J Lipid Res (1967) 0.96
Metabolism of lecithin and virus-induced cell fusion. Proc Soc Exp Biol Med (1969) 0.96
Altered phospholipid metabolism in Escherichia coli accompanying killing by disrupted granulocytes. Infect Immun (1975) 0.96
Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate. J Biol Chem (1999) 0.94
Lipid metabolism by phagocytes. Semin Hematol (1972) 0.94
Phospholipase A activity associated with membranes of human polymorphonuclear leucocytes. Biochem J (1977) 0.94
Innate immunity: from plants to humans. Immunol Today (2000) 0.94
Relation between binding and the action of phospholipases A2 on Escherichia coli exposed to the bactericidal/permeability-increasing protein of neutrophils. Biochim Biophys Acta (1987) 0.93
Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect Immun (1996) 0.92
Acylation of monoacylglycerophosphoethanolamine in the inner and outer membranes of the envelope of an Escherichia coli K12 strain and its phospholipase A-deficient mutant. Biochim Biophys Acta (1978) 0.91
Amino acid sequence of a basic Agkistrodon halys blomhoffii phospholipase A2. Possible role of NH2-terminal lysines in action on phospholipids of Escherichia coli. Biochemistry (1986) 0.91
Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins. J Biol Chem (1990) 0.90
Chylomicron-lipid-splitting activity in homogenates of rabbit polymorphonuclear leukocytes. Am J Physiol (1965) 0.90
Phospholipase activity associated with serum albumin. Biochim Biophys Acta (1973) 0.90
Oxygen-dependent and oxygen-independent mechanisms of microbicidal activity of neutrophils. Immunol Lett (1985) 0.89
Heparin inhibits phagocytosis by polymorphonuclear leukocytes. Infect Immun (1981) 0.89
Relation between calcium requirement, substrate charge, and rabbit polymorphonuclear leukocyte phospholipase A2 activity. Biochemistry (1978) 0.87
The appearance of lecithin- 32 P, synthesized from lysolecithin- 32 P, in phagosomes of polymorphonuclear leukocytes. J Clin Invest (1972) 0.86